Structural Determinants for Activity of the Antidepressant Vortioxetine at Human and Rodent 5-HT3 receptors
Lopez-Sanchez, U.; Munro, L. J.; Ladefoged, L. K.; Pedersen, A. J.; Brun, C. C.; Lyngby, S. M.; Baud, D.; Pedersen, M. G.; Lummis, S. C. R.; Bang-Andersen, B.; Schiott, B.; Chipot, C.; Schoehn, G.; Neyton, J.; Dehez, F.; Nury, H.; Kristensen, A. S.
Show abstract
Vortioxetine (VTX) is a recent antidepressant that targets a variety of serotonin receptors. We investigate the drugs molecular mechanism of operation at serotonin 5-HT3 receptors (5-HT3R), which features two mysterious properties: VTX acts differently on rodent and human 5-HT3R; VTX appears to suppress any subsequent response to agonists. Using a combination of cryo-EM, electrophysiology, and molecular dynamics, we show that VTX stabilizes a resting inhibited state of the mouse 5-HT3R and an agonist bound-like state of the human 5-HT3R, in line with the functional profile of the drug. We report four human 5-HT3R structures and show that the human receptor transmembrane domain is intrinsically fragile. We also explain the lack of recovery after VTX administration via a membrane partition mechanism.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High-resolution Structures of multiple 5-HT3AR-setron complexes reveal a novel mechanism of competitive inhibition 95%
- Mechanism of SK2 channel gating and its modulation by the bee toxin apamin and small molecules 95%
- Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.